Gene polymorphisms of <i>SFTPB</i> rs7316, rs9752 and <i>PAOX</i> rs1046175 affect the diagnostic value of plasma Pro‐SFTPB and DAS in Chinese Han non–small‐cell lung cancer patients
Kun Wang(Chinese Academy of Sciences), Yunchao Huang(North China University of Water Resources and Electric Power), Kaiyun Yang(Kunming Medical University), Qiubo Huang, Guangqiang Zhao(Kunming Medical University), Jiapeng Yang(Kunming Medical University)
Cited by 7
Related Papers
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|The Lancet Oncology|2015|1.6k
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508
Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning
|European Respiratory Journal|2019|441
The Role of Imaging in the Detection and Management of COVID-19: A Review
|IEEE Reviews in Biomedical Engineering|2020|420
A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy
|Clinical Cancer Research|2018|198